End of Pfizer-Allergan Merger Could Save U.S. Taxpayers Billions

April 6, 2016 Monika Greenhow

The withdrawal by New York-based pharma giant Pfizer of a proposed merger with Irish company Allergan could save U.S. taxpayers billions. If the merger had been completed under the Treasury Department's old rules, Pfizer could have dodged paying $35 billion in taxes on $150 billion in overseas profits. In 2014, Treasury revised rules to make it harder for corporations to use the process called "inversion" to avoid paying taxes in the United States. The AFL-CIO recently joined more than 50 organizations that sent a letter to the Treasury calling for stiffer rules on inversion so that companies are required to pay their fair share.

Previous Article
Family and Allies of Berta Cáceres Remember Her Life and Continue Her Struggle
Family and Allies of Berta Cáceres Remember Her Life and Continue Her Struggle

Like many who speak up in Honduras, indigenous leader Berta Cáceres was murdered for her activism. She was ...

Next Article
Long Overdue DOL Rule Will Protect Retirement Investors
Long Overdue DOL Rule Will Protect Retirement Investors

AFL-CIO President Richard Trumka issued the following statement in reaction to the Department of Labor's fi...